Spravato Treatment for Depression NJ
What is Spravato?
Now, FDA approved as a standalone treatment for depression, Spravato (esketamine) is an FDA-approved nasal spray designed to treat treatment-resistant depression (TRD) and other mood disorders. Unlike traditional antidepressants, Spravato works quickly and targets specific brain receptors, offering fast relief for individuals who have not responded to standard treatments. Administered under medical supervision, Spravato is a powerful option for those struggling with severe depression, especially when combined with oral antidepressants. Additionally, Spravato is covered by most insurance plans, making it a more accessible treatment option for many individuals.
*The FDA approved standalone use of J&J’s ketamine-derived depression treatment, Spravato.
How Does Spravato Work?
Spravato targets the NMDA receptors in the brain, promoting new neural connections and improving mood regulation. Its unique mechanism of action offers rapid relief, often within hours, making it ideal for individuals who need fast intervention. The treatment is administered in a safe, controlled environment at one of our New Jersey locations in Chatham, Montclair, or Westwood, where you will be closely monitored by a licensed healthcare professional.
Conditions We Treat
Experience the Change and Growth You Deserve
Depression
With a 70% increased efficacy vs. SSRIs, studies show ketamine is the most important mental health breakthrough in decades.
Suicidal Ideation
Often the result of depression or another underlying disorder, suicidal ideation can be treated with ketamine infusions.
FAQ
Popular Questions
Take a look at some science-backed answers to common questions about Spravato.